title: Melanocortin-4 receptor in sheep: a potential site for therapeutic intervention in disease models.
abstract: Reduced appetite combined with increased metabolic rate and decreased lean body mass is a major consequence of disease and other stressors. Studies in rodent species suggest that an understanding of appetite regulation may provide methodologies for intervention to prevent the deterioration of body mass such as observed with cancer or infectious diseases. For example, melanocortin-4 receptor (MC4-R) antagonists have shown a remarkable ability to reverse or prevent cachexia in rodents with sarcoma or treated with endotoxin. Studies in sheep have indicated that a number of peptide neurotransmitters may have a role in regulating appetite in this species. For example, agouti related protein mRNA and protein levels are dramatically altered with fasting in sheep. Moreover, agouti related protein, neuropeptide Y, melanin concentrating hormone and orexin are potent stimuli to increase feed intake in sheep. Recent studies have indicated that one of these neurotransmitters, NPY, can work in principal to improve appetite in endotoxin-treated sheep. Current studies are examining the role that MC4-R antagonists may have in the prevention or correction of body mass wasting diseases as well as practical applications in animal production.
authors.affiliation: Department Anatomy, Physiology & Pharmacology, Auburn University, AL 36849, USA. sartijl@vetmed.auburn.edu
authors.forename: J L
authors.initials: JL
authors.lastname: Sartin
authors.forename: C G
authors.initials: CG
authors.lastname: Wagner
authors.forename: D L
authors.initials: DL
authors.lastname: Marks
authors.forename: J A
authors.initials: JA
authors.lastname: Daniel
authors.forename: C D
authors.initials: CD
authors.lastname: McMahon
authors.forename: F Y
authors.initials: FY
authors.lastname: Obese
authors.forename: C
authors.initials: C
authors.lastname: Partridge
mesh_terms: D054369:Agouti-Related Protein; D000818:Animals; D001069:Appetite Regulation; D002100:Cachexia / Q000188:drug therapy / Q000503:physiopathology; D004194:Disease; D004195:Disease Models, Animal; D005215:Fasting; D001068:Feeding and Eating Disorders / Q000188:drug therapy; D005502:Food; D036341:Intercellular Signaling Peptides and Proteins; D009479:Neuropeptides / Q000502:physiology; D011506:Proteins / Q000502:physiology; D044105:Receptor, Melanocortin, Type 4 / Q000037:antagonists & inhibitors* / Q000502:physiology*; D012756:Sheep; D012757:Sheep Diseases / Q000503:physiopathology
chemical_list: D054369:Agouti-Related Protein; D036341:Intercellular Signaling Peptides and Proteins; D009479:Neuropeptides; D011506:Proteins; D044105:Receptor, Melanocortin, Type 4